Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients
Tonneijck L, Muskiet MHA, Twis JW, et al.
Hypertension 2018;72:314-22
Leggi
Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control
Tsujimoto T, Kajio H
Hypertension 2018;72:323-30
Leggi
Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database
Borg R, Persson F, Siersma V, et al.
Diabet Med. Pub. online 9 July 2018
Leggi
Incidence and progression of diabetic retinopathy: a systematic review
Sabanayagam C, Banu R, Chee ML, et al.
Lancet Diabetes Endocrinol. Pub. online 10 July 2018
Leggi
Diabetes and long-term outcomes of ischaemic stroke: findings from get with the guidelines-stroke
Echouffo-Tcheugui JB, Xu H, Matsouaka RA, et al.
Eur Heart J 2018;39(25):376-86
Leggi
Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink
Sattar N, McGuire DK
Circulation 2018;138:7-9
Leggi
Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes
Nassif ME, Kosiborod M
Circulation 2018;138:4-6
Leggi
Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden
Ludvigsson JF, Neovius M, Söderling J, et al.
BMJ 2018;362:k2638
Leggi
Cardioprotective anti-hyperglycaemic medications: a review of clinical trials
Ahmed HM, Khraishah H, Cho L
Eur Heart J 2018;39(25):2368-75
Leggi
Type 2 Diabetes and Risk of Incident Cancer in China: A Prospective Study Among 0.5 Million Chinese Adults
Pan X-F, He M, Yu C, et al.
Am J Epidemiol 2018;187(7):1380-91
Leggi